Latest Insider Transactions at Teladoc Health, Inc. (TDOC)
This section provides a real-time view of insider transactions for Teladoc Health, Inc. (TDOC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Teladoc Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Teladoc Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,093
+7.31%
|
-
|
|
Mar 01
2024
|
Laizer Kornwasser Advisor to the CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,409
+17.62%
|
-
|
|
Mar 01
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,558
+11.31%
|
-
|
|
Mar 01
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
52,289
+7.63%
|
-
|
|
Mar 01
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,184
+8.8%
|
-
|
|
Mar 01
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
20,426
+7.51%
|
-
|
|
Mar 01
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
475
-1.85%
|
$7,125
$15.06 P/Share
|
|
Mar 01
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,469
+20.26%
|
-
|
|
Mar 01
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,685
+2.11%
|
-
|
|
Mar 01
2024
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
105,094
+2.46%
|
-
|
|
Feb 26
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
404
-1.42%
|
$5,656
$14.5 P/Share
|
|
Feb 20
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-5.62%
|
$20,000
$20.64 P/Share
|
|
Feb 02
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,128
-21.88%
|
$78,432
$19.18 P/Share
|
|
Feb 02
2024
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
872
-6.91%
|
$16,568
$19.18 P/Share
|
|
Feb 02
2024
|
Laizer Kornwasser Advisor to the CEO |
SELL
Open market or private sale
|
Direct |
7,882
-12.11%
|
$149,758
$19.18 P/Share
|
|
Feb 02
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,523
-10.5%
|
$85,937
$19.18 P/Share
|
|
Feb 01
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,244
+35.19%
|
-
|
|
Feb 01
2024
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,020
+13.8%
|
-
|
|
Feb 01
2024
|
Laizer Kornwasser Advisor to the CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,198
+23.68%
|
-
|
|
Feb 01
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,319
+20.8%
|
-
|
|
Jan 17
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-5.32%
|
$19,000
$19.46 P/Share
|
|
Jan 03
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
520
-0.79%
|
$10,920
$21.36 P/Share
|
|
Jan 02
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,232
+1.84%
|
-
|
|
Dec 26
2023
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
27,310
-76.01%
|
$600,820
$22.0 P/Share
|
|
Dec 20
2023
|
Karen L Daniel Director |
SELL
Open market or private sale
|
Direct |
14,073
-27.56%
|
$295,533
$21.41 P/Share
|
|
Dec 18
2023
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-5.05%
|
$20,000
$20.36 P/Share
|
|
Dec 04
2023
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
397
-1.52%
|
$7,146
$18.9 P/Share
|
|
Dec 04
2023
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
410
-1.42%
|
$7,380
$18.9 P/Share
|
|
Dec 04
2023
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,877
-0.48%
|
$51,786
$18.9 P/Share
|
|
Dec 04
2023
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
508
-0.78%
|
$9,144
$18.9 P/Share
|
|
Dec 04
2023
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
427
-2.11%
|
$7,686
$18.9 P/Share
|
|
Dec 04
2023
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
965
-3.95%
|
$17,370
$18.9 P/Share
|
|
Dec 04
2023
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
509
-1.17%
|
$9,162
$18.9 P/Share
|
|
Dec 04
2023
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,004
-5.74%
|
$54,072
$18.9 P/Share
|
|
Dec 04
2023
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
652
-5.79%
|
$11,736
$18.9 P/Share
|
|
Dec 01
2023
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,347
+4.91%
|
-
|
|
Dec 01
2023
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,179
+3.93%
|
-
|
|
Dec 01
2023
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,615
+0.92%
|
-
|
|
Dec 01
2023
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,399
+1.07%
|
-
|
|
Dec 01
2023
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,179
+5.51%
|
-
|
|
Dec 01
2023
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
1,881
+7.15%
|
-
|
|
Dec 01
2023
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,404
+3.12%
|
-
|
|
Dec 01
2023
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,412
+5.02%
|
-
|
|
Dec 01
2023
|
Claus Torp Jensen CHIEF INNOVATION OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,850
+11.03%
|
-
|
|
Dec 01
2023
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,796
+5.29%
|
-
|
|
Nov 27
2023
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
346
-1.24%
|
$5,882
$17.04 P/Share
|
|
Nov 17
2023
|
Sandra L Fenwick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
436
+3.49%
|
-
|
|
Nov 17
2023
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-4.99%
|
$17,000
$17.07 P/Share
|
|
Nov 17
2023
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Bona fide gift
|
Direct |
49,096
-63.68%
|
-
|
|
Nov 17
2023
|
Karen L Daniel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
436
+0.85%
|
-
|